Navigation Links
Glenmark’s new molecule to go through trial

Glenmark Pharmaceuticals Ltd today said its newly- found andti-diabetic/anti-obesity molecule will be put into clinical trials by later this year. Mr Glenn Saldanha, Executive Director, Glenmark pharmaceuticals, told newspersons that the company’s R&D team has established ‘proof of concept’ in animals for this molecule.//

The global diabetes market is estimated to be in the region of Rs. 400 crore. The company is scouting for partners to take the molecule into advanced phases of clinical trials. Mr. Saldahna said that the pre-clinical trials for the molecule are expected to be completed in the next six months and then the Phase I clinical studies will be initiated in Europe.

"We are scouting for contract research organisations (CROs) in Europe which will take the moleucle code named - GRC -1087 - through Phase I and probably Phase II A or early Phase II clinical trials. We might be in a position to announce the CRO in the next three months," Mr Saldanha said. The clinical trials will cost around $1 millin.
'"/>




Page: 1

Related medicine news :

1. Poisonous Parkinsons molecule discovered
2. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
3. Ways to counter radiation effects with new molecule discovery
4. Same molecule found in meat, milk, tumors
5. New molecule to treat brain disorders found
6. Cell molecules behind neuro degenerative diseases
7. New anti-aging molecule could be coming up in way
8. So now here might come a memory molecule!!!
9. Lost molecule holds the key to lung cancer
10. THC molecule turns out to a boon for Alzheimer’s patient
11. Sperm washing helps couples – Breakthrough in focu
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... May 24, 2016 , ... ... announced the official relaunch of its community and education hub for women considering ... mission is to create a safe and welcoming place for women to find ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... appointment of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter ... proven leader in the development of technological innovations that lead to broad-based healthcare ...
(Date:5/24/2016)... ... May 24, 2016 , ... Bio-Logic Aqua® Research Water Life ... and a trainer for Ageless Grace ( http://www.agelessgrace.com ) to discuss healthier lifestyles, ... 16, 2016. , Formerly a Northwestern University Literature Professor, Kinst gravitated to her ...
(Date:5/24/2016)... ... May 24, 2016 , ... Controlling and maintaining the ... the launch of the Aquanta Water Heater Controller , a first-of-its-kind system that ... web-enabled device. As the Nest thermostat does for HVAC systems, Aquanta gives users ...
(Date:5/24/2016)... MA (PRWEB) , ... May 24, 2016 , ... ... Harvard Medical School, today announced a licensing relationship that will deliver a new ... This relationship will put the medical knowledge and expertise of Harvard Medical ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... UAE, May 23, 2016 Experts ... of Precision Medicine and the role of technology ...   The First International Conference of VPS-Penn Medicine ... distinguished patronage and presence of Sheikh Nahyan bin Mubarak Al ... in Precision Medicine, which helps provide personalized medicine and tailor-made ...
(Date:5/23/2016)... 23, 2016 The global  reprocessed ... billion by 2022, according to a new study by ... waste coupled with the lack of centralized support for ... drive the demand for reprocessed medical devices market. Additionally, ... to that of the original device is the high ...
(Date:5/22/2016)... DS Biopharma (DS) today ... compound DS102 in chronic obstructive pulmonary disease (COPD) ... patients. Recent DS preclinical data suggests ... and has bronchodilatory, anti-inflammatory and anti-fibrotic properties in ... will publish further detail on these findings later ...
Breaking Medicine Technology: